Bruker Co. (NASDAQ:BRKR) Shares Purchased by Quest Partners LLC

Quest Partners LLC lifted its stake in Bruker Co. (NASDAQ:BRKR) by 133.8% in the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 3,343 shares of the medical research company’s stock after purchasing an additional 1,913 shares during the quarter. Quest Partners LLC’s holdings in Bruker were worth $213,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently made changes to their positions in the stock. Lifestyle Asset Management Inc. increased its holdings in shares of Bruker by 1.3% in the first quarter. Lifestyle Asset Management Inc. now owns 12,534 shares of the medical research company’s stock valued at $1,177,000 after purchasing an additional 158 shares during the last quarter. Nisa Investment Advisors LLC increased its stake in Bruker by 20.0% during the second quarter. Nisa Investment Advisors LLC now owns 991 shares of the medical research company’s stock worth $63,000 after acquiring an additional 165 shares during the last quarter. Securian Asset Management Inc. increased its stake in Bruker by 2.3% during the second quarter. Securian Asset Management Inc. now owns 7,766 shares of the medical research company’s stock worth $496,000 after acquiring an additional 175 shares during the last quarter. Park Place Capital Corp increased its stake in Bruker by 19.4% during the first quarter. Park Place Capital Corp now owns 1,139 shares of the medical research company’s stock worth $107,000 after acquiring an additional 185 shares during the last quarter. Finally, Assetmark Inc. increased its stake in Bruker by 24.7% during the fourth quarter. Assetmark Inc. now owns 1,005 shares of the medical research company’s stock worth $74,000 after acquiring an additional 199 shares during the last quarter. Institutional investors and hedge funds own 79.52% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities research analysts have issued reports on the company. Citigroup cut their target price on Bruker from $95.00 to $80.00 and set a “buy” rating for the company in a research note on Wednesday, July 10th. Bank of America cut their target price on Bruker from $95.00 to $90.00 and set a “buy” rating for the company in a research note on Monday, May 20th. Stifel Nicolaus cut their target price on Bruker from $81.00 to $77.00 and set a “hold” rating for the company in a research note on Monday, May 20th. StockNews.com cut Bruker from a “buy” rating to a “hold” rating in a research note on Tuesday, May 21st. Finally, TD Cowen lowered their price target on Bruker from $74.00 to $72.00 and set a “hold” rating for the company in a research report on Wednesday, August 7th. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating and seven have given a buy rating to the company. Based on data from MarketBeat, Bruker currently has an average rating of “Moderate Buy” and a consensus target price of $81.40.

Bruker Trading Up 1.4 %

NASDAQ:BRKR opened at $65.66 on Monday. The firm has a market cap of $9.94 billion, a PE ratio of 23.88, a price-to-earnings-growth ratio of 2.31 and a beta of 1.18. The stock has a fifty day moving average price of $64.17 and a 200 day moving average price of $73.43. Bruker Co. has a 12-month low of $53.79 and a 12-month high of $94.86. The company has a current ratio of 1.65, a quick ratio of 0.75 and a debt-to-equity ratio of 1.18.

Bruker (NASDAQ:BRKR) last released its earnings results on Tuesday, August 6th. The medical research company reported $0.52 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.52. The firm had revenue of $800.70 million during the quarter, compared to analyst estimates of $799.44 million. Bruker had a return on equity of 24.92% and a net margin of 11.29%. Bruker’s revenue was up 17.4% compared to the same quarter last year. During the same period last year, the business posted $0.50 earnings per share. Sell-side analysts anticipate that Bruker Co. will post 2.61 earnings per share for the current fiscal year.

Bruker Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Monday, September 16th. Investors of record on Monday, September 2nd will be issued a $0.05 dividend. The ex-dividend date is Friday, August 30th. This represents a $0.20 dividend on an annualized basis and a yield of 0.30%. Bruker’s dividend payout ratio (DPR) is presently 7.27%.

Bruker Company Profile

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies.